Free Trial

Amedisys (AMED) Insider Trading & Ownership

Amedisys logo
$96.80 -0.91 (-0.93%)
(As of 11/7/2024 ET)

Amedisys (NASDAQ:AMED) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.80%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$141,250.00
Number Of
Insiders Selling
(Last 3 Years)
3
Amount Of
Insider Selling
(Last 3 Years)
$1.02 M
Get AMED Insider Trade Alerts

Want to know when executives and insiders are buying or selling Amedisys stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AMED Insider Buying and Selling by Quarter

Amedisys Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/3/2023Michael Paul NorthInsiderSell5,908$86.43$510,628.44  
6/23/2022Denise M BohnertInsiderSell557$115.00$64,055.00  
3/29/2022David L KemmerlyInsiderSell2,500$177.31$443,275.00  
11/30/2021Richard A LechleiterDirectorBuy1,000$141.25$141,250.00  
(Data available from 1/1/2013 forward)

AMED Insider Trading Activity - Frequently Asked Questions

The list of insiders at Amedisys includes David L Kemmerly, Denise M Bohnert, Michael Paul North, and Richard A Lechleiter. Learn more on insiders at AMED.

1.80% of Amedisys stock is owned by insiders. Learn more on AMED's insider holdings.

The following insider sold AMED shares in the last 24 months: Michael Paul North ($510,628.44).

Insiders have sold a total of 5,908 Amedisys shares in the last 24 months for a total of $510,628.44 sold.

Amedisys Key Executives



This page (NASDAQ:AMED) was last updated on 11/8/2024 by MarketBeat.com Staff
From Our Partners